Your session is about to expire
← Back to Search
NMDA Receptor Antagonist
OK Group for Pain
Phase 4
Waitlist Available
Led By Sergey Motov, MD
Research Sponsored by Antonios Likourezos
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 60 minutes
Awards & highlights
Summary
Acute Pain is one of the most frequent chief complaints and the main reason for visiting the Emergency Department (ED). The acute pain in the ED is largely prevalent across the country with recent literature demonstrating that 61-91% of patients are admitted to the ED due to a variety of acute painful syndromes. There is a lack of good options for pain control in such settings.
Eligible Conditions
- Pain
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 60 minutes
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~60 minutes
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Change in Pain Score at 60 Minutes
Trial Design
2Treatment groups
Active Control
Group I: OK GroupActive Control1 Intervention
Drug: Proprietary oral formulation of 0.5mg/kg of ketamine
Group II: AOK GroupActive Control1 Intervention
Drug: Proprietary oral formulation of 0.5mg/kg of ketamine + 324mg of aspirin
Find a Location
Who is running the clinical trial?
Antonios LikourezosLead Sponsor
39 Previous Clinical Trials
8,434 Total Patients Enrolled
17 Trials studying Pain
1,201 Patients Enrolled for Pain
Sergey Motov, MDPrincipal InvestigatorMaimonides Medical Center
17 Previous Clinical Trials
1,535 Total Patients Enrolled
10 Trials studying Pain
885 Patients Enrolled for Pain
Leily Naraghi Bagher Pour, MDPrincipal InvestigatorMaimonides Medical Center
Share this study with friends
Copy Link
Messenger